Nanoparticle-delivered TLR4 and RIG-I agonists enhance immune response to SARS-CoV-2 subunit vaccine.
Atalis A, Keenum MC, Pandey B, Beach A, Pradhan P, Vantucci C, O'Farrell L, Noel R, Jain R, Hosten J, Smith C, Kramer L, Jimenez A, Ochoa MA, Frey D, Roy K.
Atalis A, et al. Among authors: keenum mc.
J Control Release. 2022 Jul;347:476-488. doi: 10.1016/j.jconrel.2022.05.023. Epub 2022 May 20.
J Control Release. 2022.
PMID: 35577151
Free PMC article.